nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—Benzatropine—Hyoscyamine—pancreatitis	0.457	1	CrCrCtD
Atomoxetine—HTR2A—pancreatitis	0.34	1	CbGaD
Atomoxetine—Urinary hesitation—Propantheline—pancreatitis	0.00937	0.0847	CcSEcCtD
Atomoxetine—Strangury—Hyoscyamine—pancreatitis	0.0073	0.066	CcSEcCtD
Atomoxetine—Sinus tachycardia—Hyoscyamine—pancreatitis	0.00488	0.0441	CcSEcCtD
Atomoxetine—Mydriasis—Propantheline—pancreatitis	0.00482	0.0435	CcSEcCtD
Atomoxetine—Urinary hesitation—Hyoscyamine—pancreatitis	0.0048	0.0433	CcSEcCtD
Atomoxetine—Thirst—Propantheline—pancreatitis	0.00293	0.0265	CcSEcCtD
Atomoxetine—Mania—Hyoscyamine—pancreatitis	0.00271	0.0244	CcSEcCtD
Atomoxetine—Mydriasis—Hyoscyamine—pancreatitis	0.00247	0.0223	CcSEcCtD
Atomoxetine—Delirium—Hyoscyamine—pancreatitis	0.00229	0.0207	CcSEcCtD
Atomoxetine—Erectile dysfunction—Propantheline—pancreatitis	0.00222	0.0201	CcSEcCtD
Atomoxetine—Blood pressure increased—Hyoscyamine—pancreatitis	0.00197	0.0178	CcSEcCtD
Atomoxetine—Coma—Hyoscyamine—pancreatitis	0.0018	0.0162	CcSEcCtD
Atomoxetine—Flushing—Propantheline—pancreatitis	0.00179	0.0162	CcSEcCtD
Atomoxetine—Tension—Propantheline—pancreatitis	0.00165	0.0149	CcSEcCtD
Atomoxetine—Nervousness—Propantheline—pancreatitis	0.00163	0.0147	CcSEcCtD
Atomoxetine—Disorientation—Hyoscyamine—pancreatitis	0.0016	0.0144	CcSEcCtD
Atomoxetine—Vision blurred—Propantheline—pancreatitis	0.00158	0.0143	CcSEcCtD
Atomoxetine—Nasal congestion—Hyoscyamine—pancreatitis	0.00157	0.0142	CcSEcCtD
Atomoxetine—Thirst—Hyoscyamine—pancreatitis	0.0015	0.0136	CcSEcCtD
Atomoxetine—Palpitations—Propantheline—pancreatitis	0.00148	0.0134	CcSEcCtD
Atomoxetine—Lethargy—Hyoscyamine—pancreatitis	0.00146	0.0132	CcSEcCtD
Atomoxetine—Dry mouth—Propantheline—pancreatitis	0.0014	0.0126	CcSEcCtD
Atomoxetine—Psychotic disorder—Hyoscyamine—pancreatitis	0.00139	0.0126	CcSEcCtD
Atomoxetine—Irritability—Hyoscyamine—pancreatitis	0.00136	0.0123	CcSEcCtD
Atomoxetine—Urinary retention—Hyoscyamine—pancreatitis	0.00136	0.0123	CcSEcCtD
Atomoxetine—Tachycardia—Propantheline—pancreatitis	0.00134	0.0121	CcSEcCtD
Atomoxetine—Insomnia—Propantheline—pancreatitis	0.00124	0.0112	CcSEcCtD
Atomoxetine—Somnolence—Propantheline—pancreatitis	0.00122	0.011	CcSEcCtD
Atomoxetine—Constipation—Propantheline—pancreatitis	0.00117	0.0106	CcSEcCtD
Atomoxetine—Dysuria—Hyoscyamine—pancreatitis	0.00115	0.0104	CcSEcCtD
Atomoxetine—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00114	0.0103	CcSEcCtD
Atomoxetine—Feeling abnormal—Propantheline—pancreatitis	0.00113	0.0102	CcSEcCtD
Atomoxetine—Depression—Hyoscyamine—pancreatitis	0.0011	0.00992	CcSEcCtD
Atomoxetine—Urticaria—Propantheline—pancreatitis	0.00109	0.00984	CcSEcCtD
Atomoxetine—Conjunctivitis—Hyoscyamine—pancreatitis	0.00107	0.00967	CcSEcCtD
Atomoxetine—Asthenia—Propantheline—pancreatitis	0.000984	0.00889	CcSEcCtD
Atomoxetine—Hallucination—Hyoscyamine—pancreatitis	0.000983	0.00888	CcSEcCtD
Atomoxetine—Flushing—Hyoscyamine—pancreatitis	0.000917	0.00829	CcSEcCtD
Atomoxetine—Dizziness—Propantheline—pancreatitis	0.000907	0.00819	CcSEcCtD
Atomoxetine—Vomiting—Propantheline—pancreatitis	0.000872	0.00788	CcSEcCtD
Atomoxetine—Mental disorder—Hyoscyamine—pancreatitis	0.000866	0.00782	CcSEcCtD
Atomoxetine—Rash—Propantheline—pancreatitis	0.000865	0.00781	CcSEcCtD
Atomoxetine—Dermatitis—Propantheline—pancreatitis	0.000864	0.00781	CcSEcCtD
Atomoxetine—Headache—Propantheline—pancreatitis	0.000859	0.00776	CcSEcCtD
Atomoxetine—Tension—Hyoscyamine—pancreatitis	0.000844	0.00763	CcSEcCtD
Atomoxetine—Dysgeusia—Hyoscyamine—pancreatitis	0.000842	0.00761	CcSEcCtD
Atomoxetine—Nervousness—Hyoscyamine—pancreatitis	0.000835	0.00755	CcSEcCtD
Atomoxetine—Nausea—Propantheline—pancreatitis	0.000814	0.00736	CcSEcCtD
Atomoxetine—Vision blurred—Hyoscyamine—pancreatitis	0.000811	0.00732	CcSEcCtD
Atomoxetine—Agitation—Hyoscyamine—pancreatitis	0.00079	0.00714	CcSEcCtD
Atomoxetine—Vertigo—Hyoscyamine—pancreatitis	0.000773	0.00698	CcSEcCtD
Atomoxetine—Syncope—Hyoscyamine—pancreatitis	0.000771	0.00697	CcSEcCtD
Atomoxetine—Palpitations—Hyoscyamine—pancreatitis	0.00076	0.00687	CcSEcCtD
Atomoxetine—Loss of consciousness—Hyoscyamine—pancreatitis	0.000756	0.00683	CcSEcCtD
Atomoxetine—Convulsion—Hyoscyamine—pancreatitis	0.000745	0.00673	CcSEcCtD
Atomoxetine—Chest pain—Hyoscyamine—pancreatitis	0.000732	0.00662	CcSEcCtD
Atomoxetine—Anxiety—Hyoscyamine—pancreatitis	0.00073	0.00659	CcSEcCtD
Atomoxetine—Dry mouth—Hyoscyamine—pancreatitis	0.000716	0.00647	CcSEcCtD
Atomoxetine—Shock—Hyoscyamine—pancreatitis	0.000691	0.00624	CcSEcCtD
Atomoxetine—Tachycardia—Hyoscyamine—pancreatitis	0.000685	0.00619	CcSEcCtD
Atomoxetine—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000679	0.00613	CcSEcCtD
Atomoxetine—Insomnia—Hyoscyamine—pancreatitis	0.000635	0.00574	CcSEcCtD
Atomoxetine—Somnolence—Hyoscyamine—pancreatitis	0.000624	0.00564	CcSEcCtD
Atomoxetine—Dyspepsia—Hyoscyamine—pancreatitis	0.000618	0.00558	CcSEcCtD
Atomoxetine—Fatigue—Hyoscyamine—pancreatitis	0.000605	0.00547	CcSEcCtD
Atomoxetine—Pain—Hyoscyamine—pancreatitis	0.0006	0.00542	CcSEcCtD
Atomoxetine—Constipation—Hyoscyamine—pancreatitis	0.0006	0.00542	CcSEcCtD
Atomoxetine—Feeling abnormal—Hyoscyamine—pancreatitis	0.000578	0.00523	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000574	0.00519	CcSEcCtD
Atomoxetine—Urticaria—Hyoscyamine—pancreatitis	0.000558	0.00504	CcSEcCtD
Atomoxetine—Body temperature increased—Hyoscyamine—pancreatitis	0.000555	0.00501	CcSEcCtD
Atomoxetine—Abdominal pain—Hyoscyamine—pancreatitis	0.000555	0.00501	CcSEcCtD
Atomoxetine—Asthenia—Hyoscyamine—pancreatitis	0.000504	0.00455	CcSEcCtD
Atomoxetine—Pruritus—Hyoscyamine—pancreatitis	0.000497	0.00449	CcSEcCtD
Atomoxetine—Diarrhoea—Hyoscyamine—pancreatitis	0.00048	0.00434	CcSEcCtD
Atomoxetine—Dizziness—Hyoscyamine—pancreatitis	0.000464	0.00419	CcSEcCtD
Atomoxetine—Ketoprofen—CXCL8—pancreatitis	0.000453	0.147	CrCbGaD
Atomoxetine—Vomiting—Hyoscyamine—pancreatitis	0.000446	0.00403	CcSEcCtD
Atomoxetine—Rash—Hyoscyamine—pancreatitis	0.000443	0.004	CcSEcCtD
Atomoxetine—Dermatitis—Hyoscyamine—pancreatitis	0.000442	0.004	CcSEcCtD
Atomoxetine—Headache—Hyoscyamine—pancreatitis	0.00044	0.00397	CcSEcCtD
Atomoxetine—Nausea—Hyoscyamine—pancreatitis	0.000417	0.00377	CcSEcCtD
Atomoxetine—Pseudoephedrine—TNF—pancreatitis	0.000343	0.112	CrCbGaD
Atomoxetine—Duloxetine—HTR2A—pancreatitis	0.0003	0.0974	CrCbGaD
Atomoxetine—Fluoxetine—HTR2A—pancreatitis	0.000245	0.0794	CrCbGaD
Atomoxetine—Maprotiline—HTR2A—pancreatitis	0.000228	0.0742	CrCbGaD
Atomoxetine—Fenoprofen—PTGS2—pancreatitis	0.000224	0.0727	CrCbGaD
Atomoxetine—Fenoprofen—ALB—pancreatitis	0.000199	0.0648	CrCbGaD
Atomoxetine—Phenprocoumon—ALB—pancreatitis	0.000172	0.0559	CrCbGaD
Atomoxetine—Fluoxetine—ALB—pancreatitis	0.000167	0.0543	CrCbGaD
Atomoxetine—Warfarin—ALB—pancreatitis	0.000153	0.0496	CrCbGaD
Atomoxetine—Nortriptyline—HTR2A—pancreatitis	0.000137	0.0446	CrCbGaD
Atomoxetine—Ketoprofen—PTGS2—pancreatitis	0.000132	0.0429	CrCbGaD
Atomoxetine—Ketoprofen—ALB—pancreatitis	0.000118	0.0382	CrCbGaD
Atomoxetine—Desipramine—HTR2A—pancreatitis	0.000113	0.0367	CrCbGaD
Atomoxetine—Nortriptyline—ALB—pancreatitis	9.39e-05	0.0305	CrCbGaD
Atomoxetine—HTR2C—Signaling Pathways—SCT—pancreatitis	2.32e-05	0.000259	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CASR—pancreatitis	2.32e-05	0.000259	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—FGG—pancreatitis	2.32e-05	0.000259	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—BDKRB2—pancreatitis	2.32e-05	0.000259	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADH4—pancreatitis	2.31e-05	0.000258	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PPP3CA—pancreatitis	2.31e-05	0.000258	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CASP3—pancreatitis	2.3e-05	0.000257	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatitis	2.29e-05	0.000256	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—IL6—pancreatitis	2.29e-05	0.000256	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SST—pancreatitis	2.28e-05	0.000255	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CNR1—pancreatitis	2.27e-05	0.000254	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CX3CL1—pancreatitis	2.27e-05	0.000254	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SST—pancreatitis	2.26e-05	0.000253	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—DUSP6—pancreatitis	2.26e-05	0.000252	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	2.24e-05	0.000251	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—DUSP6—pancreatitis	2.24e-05	0.00025	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PNLIP—pancreatitis	2.24e-05	0.00025	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PRSS3—pancreatitis	2.24e-05	0.00025	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CCL5—pancreatitis	2.24e-05	0.00025	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SST—pancreatitis	2.21e-05	0.000247	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCK—pancreatitis	2.21e-05	0.000247	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MTNR1B—pancreatitis	2.21e-05	0.000247	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—GCG—pancreatitis	2.2e-05	0.000246	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—DUSP6—pancreatitis	2.19e-05	0.000245	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PRSS1—pancreatitis	2.17e-05	0.000243	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—ALB—pancreatitis	2.16e-05	0.000242	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CNR2—pancreatitis	2.16e-05	0.000241	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—A2M—pancreatitis	2.16e-05	0.000241	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TACR1—pancreatitis	2.16e-05	0.000241	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CXCL8—pancreatitis	2.15e-05	0.000241	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	2.15e-05	0.00024	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—BDKRB2—pancreatitis	2.14e-05	0.000239	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—BDKRB2—pancreatitis	2.12e-05	0.000237	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCKAR—pancreatitis	2.12e-05	0.000237	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—KNG1—pancreatitis	2.11e-05	0.000236	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CNR1—pancreatitis	2.1e-05	0.000235	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CNR1—pancreatitis	2.08e-05	0.000233	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—BDKRB2—pancreatitis	2.08e-05	0.000233	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PNLIP—pancreatitis	2.06e-05	0.00023	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PRSS3—pancreatitis	2.06e-05	0.00023	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CNR1—pancreatitis	2.04e-05	0.000228	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCL5—pancreatitis	2.03e-05	0.000227	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—GCG—pancreatitis	2.03e-05	0.000227	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—GCG—pancreatitis	2.01e-05	0.000225	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SCT—pancreatitis	2.01e-05	0.000225	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—FGG—pancreatitis	2.01e-05	0.000225	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CASR—pancreatitis	2.01e-05	0.000225	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—XDH—pancreatitis	2.01e-05	0.000225	CbGpPWpGaD
Atomoxetine—SLC6A3—Neuronal System—HRAS—pancreatitis	2e-05	0.000224	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CX3CL1—pancreatitis	1.97e-05	0.000221	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—FGA—pancreatitis	1.97e-05	0.00022	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—GCG—pancreatitis	1.97e-05	0.00022	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—HTR2A—pancreatitis	1.97e-05	0.00022	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—KNG1—pancreatitis	1.95e-05	0.000218	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	1.95e-05	0.000218	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCL5—pancreatitis	1.94e-05	0.000217	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—KNG1—pancreatitis	1.93e-05	0.000216	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NRAS—pancreatitis	1.93e-05	0.000216	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCK—pancreatitis	1.92e-05	0.000215	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MTNR1B—pancreatitis	1.92e-05	0.000215	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CCL2—pancreatitis	1.9e-05	0.000212	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—KNG1—pancreatitis	1.89e-05	0.000212	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCL2—pancreatitis	1.88e-05	0.000211	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—CTRB2—pancreatitis	1.87e-05	0.00021	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADH1B—pancreatitis	1.87e-05	0.000209	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CNR2—pancreatitis	1.87e-05	0.000209	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—A2M—pancreatitis	1.87e-05	0.000209	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TACR1—pancreatitis	1.87e-05	0.000209	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CXCL8—pancreatitis	1.87e-05	0.000209	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	1.86e-05	0.000208	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—XDH—pancreatitis	1.85e-05	0.000207	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCL2—pancreatitis	1.85e-05	0.000206	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCKAR—pancreatitis	1.84e-05	0.000206	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PTHLH—pancreatitis	1.83e-05	0.000205	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SMO—pancreatitis	1.83e-05	0.000205	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—FGB—pancreatitis	1.79e-05	0.000201	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—TGFB1—pancreatitis	1.79e-05	0.0002	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—PDGFA—pancreatitis	1.79e-05	0.0002	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HTR2A—pancreatitis	1.79e-05	0.0002	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—PDGFA—pancreatitis	1.78e-05	0.000199	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL5—pancreatitis	1.76e-05	0.000197	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—pancreatitis	1.76e-05	0.000197	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PPP3CA—pancreatitis	1.75e-05	0.000196	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—PDGFA—pancreatitis	1.74e-05	0.000195	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADH1B—pancreatitis	1.72e-05	0.000193	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—FGA—pancreatitis	1.71e-05	0.000191	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SST—pancreatitis	1.68e-05	0.000187	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—DUSP6—pancreatitis	1.66e-05	0.000186	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—KRAS—pancreatitis	1.66e-05	0.000186	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCL8—pancreatitis	1.65e-05	0.000185	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCL8—pancreatitis	1.64e-05	0.000183	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL5—pancreatitis	1.63e-05	0.000182	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—FDX1—pancreatitis	1.63e-05	0.000182	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL5—pancreatitis	1.62e-05	0.000181	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCL8—pancreatitis	1.61e-05	0.00018	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—LPL—pancreatitis	1.59e-05	0.000178	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PTHLH—pancreatitis	1.59e-05	0.000178	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SMO—pancreatitis	1.59e-05	0.000178	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL5—pancreatitis	1.58e-05	0.000177	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—LPL—pancreatitis	1.58e-05	0.000177	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—BDKRB2—pancreatitis	1.58e-05	0.000176	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—FGB—pancreatitis	1.56e-05	0.000174	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—LPL—pancreatitis	1.55e-05	0.000173	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CNR1—pancreatitis	1.55e-05	0.000173	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PPP3CA—pancreatitis	1.52e-05	0.00017	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADH4—pancreatitis	1.51e-05	0.000169	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SPP1—pancreatitis	1.51e-05	0.000169	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCL8—pancreatitis	1.5e-05	0.000168	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SPP1—pancreatitis	1.5e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—GCG—pancreatitis	1.49e-05	0.000167	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PLA2G1B—pancreatitis	1.49e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCL8—pancreatitis	1.49e-05	0.000167	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SPP1—pancreatitis	1.47e-05	0.000164	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCL8—pancreatitis	1.46e-05	0.000163	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SST—pancreatitis	1.46e-05	0.000163	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—DUSP6—pancreatitis	1.44e-05	0.000161	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—A2M—pancreatitis	1.44e-05	0.000161	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HTR2A—pancreatitis	1.44e-05	0.000161	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—KNG1—pancreatitis	1.43e-05	0.00016	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HTR2A—pancreatitis	1.42e-05	0.000159	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PRSS1—pancreatitis	1.42e-05	0.000159	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—HRAS—pancreatitis	1.41e-05	0.000158	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCL2—pancreatitis	1.4e-05	0.000156	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HTR2A—pancreatitis	1.39e-05	0.000156	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PLA2G1B—pancreatitis	1.37e-05	0.000154	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—BDKRB2—pancreatitis	1.37e-05	0.000153	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL6—pancreatitis	1.35e-05	0.000151	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PRSS3—pancreatitis	1.35e-05	0.000151	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PNLIP—pancreatitis	1.35e-05	0.000151	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CNR1—pancreatitis	1.34e-05	0.00015	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—LEP—pancreatitis	1.33e-05	0.000149	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—A2M—pancreatitis	1.33e-05	0.000148	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—LEP—pancreatitis	1.32e-05	0.000148	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALDH2—pancreatitis	1.32e-05	0.000148	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—PDGFA—pancreatitis	1.32e-05	0.000147	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—GCG—pancreatitis	1.3e-05	0.000145	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—LEP—pancreatitis	1.3e-05	0.000145	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.29e-05	0.000144	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—KNG1—pancreatitis	1.25e-05	0.000139	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCL8—pancreatitis	1.22e-05	0.000136	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL2—pancreatitis	1.21e-05	0.000136	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALDH2—pancreatitis	1.21e-05	0.000136	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—XDH—pancreatitis	1.21e-05	0.000135	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—NRAS—pancreatitis	1.2e-05	0.000135	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL5—pancreatitis	1.2e-05	0.000134	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—NRAS—pancreatitis	1.2e-05	0.000134	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—LPL—pancreatitis	1.17e-05	0.000131	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—NRAS—pancreatitis	1.17e-05	0.000131	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.16e-05	0.000129	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—PDGFA—pancreatitis	1.15e-05	0.000128	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—INS—pancreatitis	1.14e-05	0.000127	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—INS—pancreatitis	1.13e-05	0.000127	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADH1B—pancreatitis	1.13e-05	0.000126	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL2—pancreatitis	1.12e-05	0.000125	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL2—pancreatitis	1.11e-05	0.000124	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SPP1—pancreatitis	1.11e-05	0.000124	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—INS—pancreatitis	1.11e-05	0.000124	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL8—pancreatitis	1.11e-05	0.000124	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL2—pancreatitis	1.09e-05	0.000122	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL8—pancreatitis	1.06e-05	0.000118	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HTR2A—pancreatitis	1.06e-05	0.000118	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL5—pancreatitis	1.04e-05	0.000116	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—KRAS—pancreatitis	1.04e-05	0.000116	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—KRAS—pancreatitis	1.03e-05	0.000115	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LPL—pancreatitis	1.02e-05	0.000114	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.01e-05	0.000113	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—KRAS—pancreatitis	1.01e-05	0.000113	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GCG—pancreatitis	1e-05	0.000112	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—LEP—pancreatitis	9.83e-06	0.00011	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SPP1—pancreatitis	9.64e-06	0.000108	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL8—pancreatitis	9.6e-06	0.000107	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MDM2—pancreatitis	9.49e-06	0.000106	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MDM2—pancreatitis	9.41e-06	0.000105	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MDM2—pancreatitis	9.22e-06	0.000103	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GCG—pancreatitis	9.2e-06	0.000103	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PLA2G1B—pancreatitis	8.98e-06	0.0001	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—NRAS—pancreatitis	8.87e-06	9.92e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL8—pancreatitis	8.87e-06	9.92e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—HRAS—pancreatitis	8.81e-06	9.85e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL8—pancreatitis	8.8e-06	9.84e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—HRAS—pancreatitis	8.74e-06	9.78e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—A2M—pancreatitis	8.68e-06	9.7e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL8—pancreatitis	8.62e-06	9.64e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—HRAS—pancreatitis	8.56e-06	9.57e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—LEP—pancreatitis	8.53e-06	9.54e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CASP3—pancreatitis	8.49e-06	9.49e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—pancreatitis	8.43e-06	9.43e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CASP3—pancreatitis	8.42e-06	9.42e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—INS—pancreatitis	8.4e-06	9.39e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—pancreatitis	8.37e-06	9.36e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL2—pancreatitis	8.26e-06	9.24e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CASP3—pancreatitis	8.25e-06	9.22e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—pancreatitis	8.19e-06	9.16e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALDH2—pancreatitis	7.94e-06	8.87e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—LPL—pancreatitis	7.85e-06	8.78e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—NRAS—pancreatitis	7.7e-06	8.61e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—KRAS—pancreatitis	7.63e-06	8.54e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—INS—pancreatitis	7.29e-06	8.15e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—LPL—pancreatitis	7.22e-06	8.07e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL2—pancreatitis	7.17e-06	8.02e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NRAS—pancreatitis	7.12e-06	7.96e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NRAS—pancreatitis	7.06e-06	7.89e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MDM2—pancreatitis	6.99e-06	7.81e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NRAS—pancreatitis	6.91e-06	7.73e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—KRAS—pancreatitis	6.63e-06	7.41e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TGFB1—pancreatitis	6.61e-06	7.39e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TGFB1—pancreatitis	6.56e-06	7.34e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL8—pancreatitis	6.53e-06	7.3e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—HRAS—pancreatitis	6.49e-06	7.25e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TGFB1—pancreatitis	6.42e-06	7.18e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CASP3—pancreatitis	6.25e-06	6.99e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—pancreatitis	6.21e-06	6.94e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—KRAS—pancreatitis	6.12e-06	6.85e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—KRAS—pancreatitis	6.08e-06	6.79e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MDM2—pancreatitis	6.07e-06	6.78e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GCG—pancreatitis	6.01e-06	6.72e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—KRAS—pancreatitis	5.95e-06	6.65e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARG—pancreatitis	5.73e-06	6.41e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL8—pancreatitis	5.67e-06	6.34e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—HRAS—pancreatitis	5.63e-06	6.3e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—INS—pancreatitis	5.62e-06	6.28e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CASP3—pancreatitis	5.43e-06	6.07e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—pancreatitis	5.39e-06	6.03e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARG—pancreatitis	5.27e-06	5.89e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NRAS—pancreatitis	5.24e-06	5.86e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—HRAS—pancreatitis	5.21e-06	5.82e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—INS—pancreatitis	5.17e-06	5.78e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—HRAS—pancreatitis	5.17e-06	5.78e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ALB—pancreatitis	5.15e-06	5.76e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—HRAS—pancreatitis	5.06e-06	5.66e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—pancreatitis	4.98e-06	5.57e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—pancreatitis	4.94e-06	5.53e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TGFB1—pancreatitis	4.87e-06	5.44e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—pancreatitis	4.84e-06	5.41e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ALB—pancreatitis	4.74e-06	5.3e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—LPL—pancreatitis	4.72e-06	5.28e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NRAS—pancreatitis	4.55e-06	5.09e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—KRAS—pancreatitis	4.51e-06	5.04e-05	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PTGS2—pancreatitis	4.51e-06	5.04e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TGFB1—pancreatitis	4.23e-06	4.73e-05	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PTGS2—pancreatitis	4.15e-06	4.64e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—KRAS—pancreatitis	3.92e-06	4.38e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—HRAS—pancreatitis	3.83e-06	4.29e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—pancreatitis	3.67e-06	4.1e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARG—pancreatitis	3.45e-06	3.85e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—INS—pancreatitis	3.38e-06	3.78e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—HRAS—pancreatitis	3.33e-06	3.72e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—pancreatitis	3.19e-06	3.56e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ALB—pancreatitis	3.1e-06	3.46e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PTGS2—pancreatitis	2.71e-06	3.03e-05	CbGpPWpGaD
